The clinical introduction of hepcidin25 (Hep25) has led to a more detailed understanding of its relationship with ferroportin (FP) and divalent metal transporter1 in primary
Researchers from the Organoid group have developed a new organoid model that can be used to study the thymus.
Becky Watkins, Senior VP of Client Solutions of ResultsCX When interacting with industries such as retail, hospitality, and finance, we’ve all become accustomed to quick,
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q1 revenue: 4.14 billion
LONDON, April 29, 2024 (GLOBE NEWSWIRE) — Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in
VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”) proudly announces a milestone accomplishment from its
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today
People with heart disease may receive different care because of how race is interpreted in health risk calculators and other tools that help clinicians make